ImageneBio IMA
NASDAQ IMA
$3.72 -0.09 (-2.36%)
As of: Nov 11, 2026 · 3:56 PM EST

ImageneBio (IMA) Debt Ratio (2023 - 2024)

Updated

ImageneBio's (IMA) Debt Ratio was 0.54 for Q4 2024, compared with 0.00 a year earlier.

Analysis

ImageneBio (IMA) Debt Ratio (2023 - 2024) Analysis & Trends

  • By year, Debt Ratio came in at 0.00 in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.33
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.23
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.55
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.41
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -0.06
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.56
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.51
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 ImageneBio 65.24 Mn -450.07 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 0.54
Dec 31, 2023 0.00
Sep 30, 2023 0.00
API Access

ImageneBio Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=IMA&period=max&api_key=YOUR_API_KEY